Real-World Experience with Dolutegravir-Based Two-Drug Regimens
Background. Dolutegravir-based 2-drug regimens (DTG 2DRs) are now accepted as alternatives to 3-drug regimens for HIV antiretroviral treatment (ART); however, literature on physician drivers for prescribing DTG 2DR is sparse. This study evaluated treatment patterns of DTG 2DR components in clinical...
Saved in:
Main Authors: | Douglas Ward, Moti Ramgopal, David J. Riedel, Cindy Garris, Shelly Dhir, John Waller, Jenna Roberts, Katie Mycock, Alan Oglesby, Bonnie Collins, Megan Dominguez, James Pike, Joseph Mrus |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | AIDS Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2020/5923256 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hospitalization outcomes in people living with HIV on Dolutegravir-based regimen in Mwanza, Tanzania: a comparative cohort
by: Godfrey A. Kisigo, et al.
Published: (2025-02-01) -
HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique
by: Nalia Ismael, et al.
Published: (2025-01-01) -
International Normalized Ratio (INR) Increases amongst Two Patients Living with HIV on Warfarin after Being Switched from a Nevirapine to a Dolutegravir-Based Antiretroviral Regimen
by: Natalie Sang, et al.
Published: (2021-01-01) -
Exploring the Solubility and Bioavailability of Sodium Salt and Its Free Acid Solid Dispersions of Dolutegravir
by: Dani Lakshman Yarlagadda, et al.
Published: (2023-01-01) -
Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review
by: William R. Short, et al.
Published: (2024-12-01)